首页> 外国专利> Derivatives, having an inhibitory action against protease and an antiphlogistic action, of the trypsin-kallikrein inhibitor obtained from cattle organs (BPTI), their preparation and their use as medicaments

Derivatives, having an inhibitory action against protease and an antiphlogistic action, of the trypsin-kallikrein inhibitor obtained from cattle organs (BPTI), their preparation and their use as medicaments

机译:从牛器官获得的胰蛋白酶-激肽释放酶抑制剂(BPTI)的具有抗蛋白酶抑制作用和消炎作用的衍生物,其制备方法和用作药物的用途

摘要

The invention provides derivatives of kallikrein-trypsin inhibitor (BPTI) in which one or both of the 10- or 21-tyrosine residues are linked, in the o-position relative to the phenolic hydroxyl group, to an aptionally substituted carbocyclic or heterocyclic aromatic radical via an azo group and the other if only one of the said residues is substituted is either unsubstituted or carries a nitro group or an amino group in the o-position relative to the phenolic hydroxyl group.P P The azo-BPTI derivatives of the invention can be used, as medicaments for the therapy of diseases which are caused either by over- production of proteases as a result of increased liberation from the zymogens or of release during cell decomposition or by a deficiency or lack of natural indogenous inhibitors of these enzymes in organs and tissue fluids. Diseases which have this type of etiology are the various forms of shock and post-traumatic or post-operative complications, disorders in blood clotting and acute and chronic inflammatory reactions and, in particular, also chronic inflammatory reactions with necrotic and degenerative damage to connective tissue, such as pancreatitis and also vasculitides, glomerulonephritides, rheumatoid arthritis and other collagenoses caused by immune complexes and also arthritides caused by deposits due to metabolic processes (gout), but also degenerative changes in the elastic elements of vascular walls (arterioscleroses) or in the lung (pulmonary emphysema).
机译:本发明提供激肽释放酶-胰蛋白酶抑制剂(BPTI)的衍生物,其中10-或21-酪氨酸残基中的一个或两个在相对于酚羟基的o-位连接到适当取代的碳环或杂环芳族基团如果仅一个所述残基被取代,则通过偶氮基和另一个取代基是未取代的,或相对于酚羟基在邻位带有硝基或氨基。

偶氮-BPTI可以将本发明的衍生物用作治疗疾病的药物,这些疾病是由于从酶原中释放的增加或细胞分解过程中的释放而导致的蛋白酶过量产生,或者由于缺乏或缺乏天然的内源性抑制剂引起的这些酶在器官和组织液中的含量。具有这种病因的疾病是各种形式的休克和创伤后或手术后并发症,凝血障碍以及急性和慢性炎症反应,尤其是慢性炎症反应,对结缔组织具有坏死性和退化性损害如胰腺炎,以及由于免疫复合物引起的血管炎,肾小球磷脂,类风湿性关节炎和其他胶原蛋白,以及由于代谢过程(痛风)引起的沉积物引起的关节炎,以及血管壁弹性成分(动脉硬化性玫瑰)或血管壁的退行性改变肺(肺气肿)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号